How Stereotactic Radiotherapy Differs From Traditional Radiation Therapy

What is less clear is that not all radiotherapy is delivered in the same way. Stereotactic radiotherapy and traditional radiation therapy both use radiation to treat cancer, but they differ significantly in how that treatment is planned, delivered, and how it affects surrounding tissue.

Understanding that difference helps explain why one approach may be recommended over another.

What traditional radiation therapy involves

Traditional radiation therapy, often referred to as conventional radiotherapy, delivers radiation in smaller doses over a longer period of time.

Treatment is usually given five days a week over several weeks. Each session delivers a fraction of the total dose, allowing healthy tissue time to recover between treatments.

This approach has been used effectively for many years and remains a standard option for a wide range of cancers, including lung cancer.

The principle is straightforward. By spreading the dose over time, the treatment balances effectiveness against the risk of damage to surrounding tissue.

What stereotactic radiotherapy does differently

Stereotactic radiotherapy takes a different approach. Instead of delivering small doses over many sessions, it delivers a much higher dose of radiation in a small number of treatments, often between one and five.

What makes this possible is precision.

The radiation is carefully shaped and directed to match the exact position and size of the tumour. Advanced imaging and motion management techniques allow the treatment to account for natural movement, such as breathing, particularly in lung cancer.

In simple terms, it is a more focused form of radiotherapy.

The aim is not just to treat the tumour, but to do so with as little impact as possible on surrounding tissue. This level of precision is one of the reasons stereotactic radiotherapy can be highly successful in selected cases, particularly when the tumour is well defined and localised.

The key difference: precision and dose delivery

The main difference between these approaches comes down to how radiation is delivered.

Traditional radiotherapy delivers lower doses over more sessions and typically treats a broader area.

Stereotactic radiotherapy delivers higher doses in fewer sessions with a much more targeted approach.

That difference changes both the treatment experience and the expected outcomes.

With stereotactic radiotherapy, the ability to deliver a high dose directly to the tumour can improve local control in certain cases, particularly when the tumour is well defined.

At the same time, reducing radiation to surrounding tissue can lower the risk of some side effects.

How this applies in lung cancer

In lung cancer, the choice between these approaches depends on the specific situation.

Traditional radiotherapy is often used when a larger area needs to be treated. This may include cases where the cancer involves lymph nodes or is more widespread within the chest.

Stereotactic radiotherapy is usually considered when the disease is more localised.

It is commonly used for early-stage lung cancer, particularly when surgery is not an option. It may also be used to treat small, isolated areas of disease.

What this means in practice is that the treatment goal is more focused. The intention is often to treat a defined tumour with a high level of precision, sometimes with curative intent.

This is where planning becomes critical, particularly when the tumour sits close to surrounding structures and accuracy becomes more important.

Differences in treatment experience

From a patient’s perspective, the experience can feel quite different.

Traditional radiotherapy requires a longer commitment. Treatment may take place over several weeks, with daily visits to the treatment centre.

Stereotactic radiotherapy is typically completed in far fewer sessions. That shorter timeframe can be more convenient, particularly for patients who may find frequent hospital visits challenging.

However, the intensity of each session is higher.

The experience is not necessarily easier, just different. The planning is more detailed, and accuracy is critical for each treatment.

Both approaches are well established, and both are used with clear clinical reasoning.

Side effects and safety considerations

Side effects depend on the area being treated and the total dose of radiation.

Traditional radiotherapy spreads exposure over a wider area, which can sometimes lead to broader but more gradual side effects, such as fatigue building up over several weeks or mild skin redness/irritation in the treated region.

Stereotactic radiotherapy, by contrast, limits exposure to surrounding tissue while delivering a higher dose to a smaller area. This can reduce widespread effects like extensive skin irritation, but it may cause more localized, short-term reactions such as temporary swelling/inflammation near the target (e.g., headaches after brain treatment) or localized soreness in the treated spot.

In lung cancer, this can include temporary inflammation of the lung tissue, cough, or fatigue, although many patients tolerate treatment well.

The key point is that neither approach is universally better.

Each has advantages depending on the situation.

How treatment decisions are made

The decision between stereotactic and traditional radiotherapy is not based on a single factor.

It depends on the stage of the cancer, the size and location of the tumour, whether lymph nodes are involved, and the patient’s overall health.

Even when two cases appear similar at first, the details can lead to very different recommendations.

Stereotactic radiotherapy represents a shift towards more precise cancer treatment. It does not replace traditional radiotherapy, but it expands what is possible in certain situations. Having both options available allows treatment to be tailored more closely to the individual.

In practice, this is where careful interpretation becomes important. In more complex cases, particularly where the balance between effectiveness and safety is less clear, working with a private oncology consultant can help ensure that decisions are guided by a more detailed and individualised assessment.

The aim is always to select the approach that provides the best balance between effectiveness and safety for that particular situation.

About Dr James Wilson

Dr James Wilson is a consultant clinical oncologist specialising in lung cancer and advanced radiotherapy techniques. Based in a full-time private practice in Central London, he focuses on delivering precise, carefully structured treatment plans, particularly when decisions require clarity and a high degree of clinical judgement.